Chinese Public Payer Data Show More New Drugs Get Faster Coverage

But Pricing Trade-Off

 
• By Dexter Jie Yan
  
NHSA spending on novel drugs
China's public payer spends more on novel drugs but their share of total health expense rose only slowly • Source: Shutterstock

More from China

More from Focus On Asia